Literature DB >> 17241907

MHC class I antigens and immune surveillance in transformed cells.

Natalia Aptsiauri1, Teresa Cabrera, Angel Garcia-Lora, Miguel Angel Lopez-Nevot, Francisco Ruiz-Cabello, Federico Garrido.   

Abstract

MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic activity of natural killer (NK) cells. In this review we discuss the role of MHC class I antigens in the recognition and elimination of transformed cells and in the generation of tumor immune escape routes when MHC class I losses occur in tumors. The different altered MHC class I phenotypes and their distribution in different human tumors are the main topic of this review. In addition, molecular defects that underlie MHC alterations in transformed cells are also described in detail. Future research directions in this field are also discussed, including the laboratory analysis of tumor MHC class I-negative variants and the possible restoration of MHC class I expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241907     DOI: 10.1016/S0074-7696(07)56005-5

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  53 in total

1.  Analysis of HLA-ABC locus-specific transcription in normal tissues.

Authors:  Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Immunogenetics       Date:  2010-09-15       Impact factor: 2.846

2.  Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Authors:  Mohanraj Sadasivam; Sanjeev Noel; Sul A Lee; Jing Gong; Mohamad E Allaf; Phillip Pierorazio; Hamid Rabb; Abdel Rahim A Hamad
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

3.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Authors:  Joëlle Riond; Stéphane Rodriguez; Marie-Laure Nicolau; Talal al Saati; Jean Edouard Gairin
Journal:  Cancer Immun       Date:  2009-11-02

4.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.

Authors:  Yonggui Fu; Yu Sun; Yuxin Li; Jie Li; Xingqiang Rao; Chong Chen; Anlong Xu
Journal:  Genome Res       Date:  2011-04-07       Impact factor: 9.043

5.  Immunotherapy: Tumor-infiltrating T cells--ready for prime time in melanoma?

Authors:  Jason Chesney; Kelly M McMasters
Journal:  Nat Rev Clin Oncol       Date:  2011-07-05       Impact factor: 66.675

6.  Alternation of gene expression in trigeminal ganglion neurons following complete Freund's adjuvant or capsaicin injection into the rat face.

Authors:  Masayo Okumura; Koichi Iwata; Koichi Yasuda; Katsuhiro Inoue; Masamichi Shinoda; Kuniya Honda; Kazuo Shibuta; Masashi Yasuda; Eiji Kondo
Journal:  J Mol Neurosci       Date:  2010-03-28       Impact factor: 3.444

7.  MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.

Authors:  Elena Catalán; Seyma Charni; Paula Jaime; Juan Ignacio Aguiló; José Antonio Enríquez; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

8.  Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.

Authors:  Diego Chowell; Luc G T Morris; Claud M Grigg; Jeffrey K Weber; Robert M Samstein; Vladimir Makarov; Fengshen Kuo; Sviatoslav M Kendall; David Requena; Nadeem Riaz; Benjamin Greenbaum; James Carroll; Edward Garon; David M Hyman; Ahmet Zehir; David Solit; Michael Berger; Ruhong Zhou; Naiyer A Rizvi; Timothy A Chan
Journal:  Science       Date:  2017-12-07       Impact factor: 47.728

9.  Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.

Authors:  Simon Turcotte; Alena Gros; Eric Tran; Chyi-Chia R Lee; John R Wunderlich; Paul F Robbins; Steven A Rosenberg
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531

10.  Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.

Authors:  Juliane S Stickel; Natalie Stickel; Jörg Hennenlotter; Karin Klingel; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Journal:  BMC Urol       Date:  2011-01-20       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.